Combination of AI & Radiologists more Accurately Identified Breast Cancer

An artificial intelligence (AI) tool - trained on roughly a million screening mammography images - identified breast cancer with approximately 90 percent accuracy when combined with analysis by radiologists, a new study finds. Led by researchers from NYU School of Medicine and the NYU Center for Data Science, the study examined the ability of a type of AI, a machine learning computer program, to add value to the diagnoses reached by a group of 14 radiologists as they reviewed 720 mammogram images.

"Our study found that AI identified cancer-related patterns in the data that radiologists could not, and vice versa," says senior study author Krzysztof J. Geras, PhD, assistant professor in the Department of Radiology at NYU Langone.

"AI detected pixel-level changes in tissue invisible to the human eye, while humans used forms of reasoning not available to AI," adds Dr. Geras, also an affiliated faculty member at the NYU Center for Data Science. "The ultimate goal of our work is to augment, not replace, human radiologists."

In 2014, more than 39 million mammography exams were performed in the United States to screen women (without symptoms) for breast cancer and determine those in need of closer follow-up. Women whose test results yield abnormal mammography findings are referred for biopsy, a procedure that removes a small sample of breast tissue for laboratory testing.

A New Tool to Identify Breast Cancer

In the new study, the research team designed statistical techniques that let their program "learn" how to get better at a task without being told exactly how. Such programs build mathematical models that enable decision-making based on data examples fed into them, with the program getting "smarter" as it reviews more and more data.

Modern AI approaches, inspired by the human brain, use complex circuits to process information in layers, with each step feeding information into the next, and assigning more or less importance to each piece of information along the way.

Published online recently by the journal IEEE Transactions on Medical Imaging, the current study authors trained their AI tool on many images matched with the results of biopsies performed in the past. Their goal was to enable the tool to help radiologists reduce the number biopsies needed moving forward. This can only be achieved, says Dr. Geras, by increasing the confidence that physicians have in the accuracy of assessments made for screening exams (for example, reducing false-positive and false-negative results).

For the current study, the research team analyzed images that had been collected as part of routine clinical care at NYU Langone Health over seven years, sifting through the collected data and connecting the images with biopsy results. This effort created an extraordinarily large dataset for their AI tool to train on, say the authors, consisting of 229,426 digital screening mammography exams and 1,001,093 images. Most databases used in studies to date have been limited to 10,000 images or fewer.

Thus, the researchers trained their neural network by programming it to analyze images from the database for which cancer diagnoses had already been determined. This meant that researchers knew the "truth" for each mammography image (cancer or not) as they tested the tool's accuracy, while the tool had to guess. Accuracy was measured in the frequency of correct predictions.

In addition, the researchers designed the study AI model to first consider very small patches of the full resolution image separately to create a heat map, a statistical picture of disease likelihood. Then the program considers the entire breast for structural features linked to cancer, paying closer attention to the areas flagged in the pixel-level heat map.

Rather than have the researchers identify image features for their AI to search for, the tool is discovering on its own which image features increase prediction accuracy. Moving forward, the team plans to further increase this accuracy by training the AI program on more data, perhaps even identifying changes in breast tissue that are not yet cancerous but have the potential to be.

"The transition to AI support in diagnostic radiology should proceed like the adoption of self-driving cars - slowly and carefully, building trust, and improving systems along the way with a focus on safety," says first author Nan Wu, a doctoral candidate at the NYU Center for Data Science.

Nan Wu, Jason Phang, Jungkyu Park, Yiqiu Shen, Zhe Huang, Masha Zorin, Stanisław Jastrzębski, Thibault Févry, Joe Katsnelson, Eric Kim, Stacey Wolfson, Ujas Parikh, Sushma Gaddam, Leng Leng Young Lin, Kara Ho, Joshua D. Weinstein, Beatriu Reig, Yiming Gao, Hildegard Toth Kristine Pysarenko, Alana Lewin, Jiyon Lee, Krystal Airola, Eralda Mema, Stephanie Chung, Esther Hwang, Naziya Samreen, S Gene Kim, Laura Heacock, Linda Moy, Kyunghyun Cho.
Deep Neural Networks Improve Radiologists' Performance in Breast Cancer Screening.
IEEE Transactions on Medical Imaging. doi: 10.1109/TMI.2019.2945514.

Most Popular Now

Researchers Capture First Images of Oxyg…

Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful. Hypoxia, or starvation of oxygen, in solid tumors is also thought to be...

VTT Makes New Investments in Digital Hea…

VTT is launching new research activities in the area of digital health as part of the growing wellbeing and health technology ecosystem in Kuopio. The new initiative aims to create...

A New Method of Artificial Intelligence …

Despite the immense progress in the field of AI in recent years, we are still very far from human intelligence. Indeed, if current AI techniques allow to train computer agents...

FDA Informs Health Care Providers, Facil…

Today, the U.S. Food and Drug Administration is issuing a safety communication informing health care providers, facilities and patients about cybersecurity vulnerabilities identified for certain GE Healthcare Clinical Information Central...

eHealthWeek 2020 Croatia - Trusted Infor…

15 - 17 April 2020, Rovinj, Croatia. In its capacity of hosting the upcoming Presidency of the Council of the European Union, the Croatian Ministry of Health is in preparations to...

Siemens Healthineers Presents Solutions …

CT scanners with intelligent user guidance, AI-based software assistants for MRI and a lab system that revolutionizes workflows: Siemens Healthineers is showcasing its products and solutions according to the motto...

NHS IT Chiefs Set the Stage for a Year o…

3 - 4 March 2019, London, United Kingdom. NHS technology leaders are to kick off the second-ever Digital Health Rewired Conference and Exhibition on 3 - 4 March at the Olympia...

PatchAi Startup has Arrived in the Marke…

PatchAi - a startup that offers, thanks to Artificial Intelligence and Machine Learning, an empathic virtual assistant to patients participating in clinical trials - announced that it has closed two...

Digital Health App Medicus AI Earns CE C…

Medicus AI, the Vienna-based health tech company, has received a ​Class I Medical Device CE Mark for its mobile application. The CE certification mark confirms that Medicus AI conforms to...

Refining Breast Cancer Classification by…

Breast cancer progression can vary significantly between patients. Even within the same tumor, different areas may be composed of different types of cells and characterized by different tumor structures. This...

Human Body-on-Chip Platform Enables In V…

Drug development is an extremely arduous and costly process, and failure rates in clinical trials that test new drugs for their safety and efficacy in humans remain very high. According...

FDA Authorizes Marketing of First Cardia…

Today, the U.S. Food and Drug Administration authorized marketing of software to assist medical professionals in the acquisition of cardiac ultrasound, or echocardiography, images. The software, called Caption Guidance, is...